Position in LH
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$7,898,240
+$714,114 QoQ
Shares Held
28,208
+4.8% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#198
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Handelsbanken Fonder AB holds $615,388,402 across 24 Diagnostics & Research names. LH ranks #12 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
538,524 | $269,994,392 | |
| 2 | NTRA |
Natera, Inc.
|
207,800 | $56,407,310 | |
| 3 | DHR |
Danaher Corp /De/
|
289,223 | $55,091,197 | |
| 4 | GH |
Guardant Health, Inc.
|
301,041 | $45,165,181 | |
| 5 | WAT |
Waters Corp /De/
|
93,653 | $35,123,621 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
163,816 | $31,652,527 | |
| 7 | A |
Agilent Technologies, Inc.
|
162,195 | $21,544,361 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
38,344 | $20,185,815 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,898,240 | 28,208 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $7,184,126 | 26,926 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $8,078,085 | 32,199 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $7,870,898 | 27,419 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,774,531 | 18,188 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,427,180 | 19,022 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $3,870,233 | 16,877 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $5,081,488 | 22,738 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $5,458,341 | 26,821 | Shares | Sole | 2024-08-05 | |
| No filing history on record for this holder in this stock. | ||||||